Michael C. Kennedy
FDA investigator
Appears on 1 document from 2012, mostly at sites in Florida. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 13.0
- Observations per 483
- 2012
- First seen
- 2012
- Most recent
What they cite most
From 13 observations- 21 CFR 211.100Written procedures; deviations6
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.160General requirements2
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.170Reserve samples1
Activity by year
2012: 1
Where
Florida 1
Often inspects with
Is Michael C. Kennedy coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2012-05-17 | 483 ADMA Biologics, IncMay 17, 2012 · Boca Raton, Florida | Boca Raton, Florida | 13 |
About this profile
What does Michael C. Kennedy inspect?
Michael C. Kennedy appears on 1 document on file covering 1 site, mostly in Florida.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.110 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Michael C. Kennedy is dated May 17, 2012.